a month ago
AXSM
AnalystsSean LaamanSean Laaman's Stock Forecasts
AnalystsSean Laaman
Analyst Ranking
Top 23%
#1142 out of 5116 analysts
Average Return
+27.57%
Win Rate
89%16 out of 18
Risk vs Reward
Poor
Good
Sean Laaman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Resmed IncRMD | +90.17% | $134.65 | $256.07 | 2023-10-27 - 2024-10-25 | Strong Buy |
Disc Medicine IncIRON | +70.52% | $54.75 | $93.36 | 2025-07-03 - 2025-11-28 | Strong Buy |
Beone Medicines LtdONC | +65.34% | $206.01 | $340.61 | 2024-12-03 - 2025-11-28 | Strong Buy |
Disc Medicine IncIRON | +58.67% | $58.84 | $93.36 | 2025-08-18 - 2025-11-28 | Strong Buy |
Axsome Therapeutics IncAXSM | +43.68% | $105.44 | $151.50 | 2025-07-03 - 2025-11-28 | Strong Buy |
Sean Laaman Analyst Color
Get additional color on Sean Laaman's coverage of popular stocks
a month ago
ONC
Sean Laaman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maplight Therapeutics IncMPLT | 1 | Strong Buy | $34.00 | +149.45% | Initiates Coverage On | 9 days ago |
Exelixis IncEXEL | 4 | Strong Buy | $45.00 | +1.88% | Maintains | 25 days ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $196.00 | +29.37% | Maintains | a month ago |
Disc Medicine IncIRON | 3 | Strong Buy | $115.00 | +23.18% | Maintains | a month ago |
Resmed IncRMD | 2 | Strong Buy | $304.00 | +18.83% | Maintains | a month ago |
Beone Medicines LtdONC | 3 | Strong Buy | $383.00 | +12.45% | Maintains | a month ago |
Certara IncCERT | 1 | Hold | $16.00 | +74.67% | Assumes | 5 months ago |
Alector IncALEC | 1 | Strong Sell | $1.50 | +12.78% | Assumes | 9 months ago |
Halozyme Therapeutics IncHALO | 1 | Strong Buy | $67.00 | -6.16% | Assumes | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.